IRadimed Corporation
IRMD
$97.14
$0.880.91%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 22.69M | 21.20M | 20.41M | 19.51M | 19.39M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 22.69M | 21.20M | 20.41M | 19.51M | 19.39M |
| Cost of Revenue | 5.66M | 4.71M | 4.45M | 4.67M | 4.63M |
| Gross Profit | 17.03M | 16.49M | 15.96M | 14.84M | 14.76M |
| SG&A Expenses | 9.16M | 8.99M | 8.30M | 8.80M | 8.43M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 15.60M | 14.37M | 13.62M | 14.08M | 13.59M |
| Operating Income | 7.09M | 6.83M | 6.79M | 5.43M | 5.80M |
| Income Before Tax | 7.79M | 7.30M | 7.33M | 5.95M | 6.34M |
| Income Tax Expenses | 1.35M | 1.72M | 1.55M | 1.26M | 1.20M |
| Earnings from Continuing Operations | 6.44M | 5.58M | 5.77M | 4.69M | 5.15M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 6.44M | 5.58M | 5.77M | 4.69M | 5.15M |
| EBIT | 7.09M | 6.83M | 6.79M | 5.43M | 5.80M |
| EBITDA | 7.47M | 7.22M | 7.00M | 5.63M | 6.00M |
| EPS Basic | 0.51 | 0.44 | 0.45 | 0.37 | 0.41 |
| Normalized Basic EPS | 0.37 | 0.36 | 0.36 | 0.29 | 0.31 |
| EPS Diluted | 0.50 | 0.43 | 0.45 | 0.37 | 0.40 |
| Normalized Diluted EPS | 0.37 | 0.35 | 0.36 | 0.29 | 0.31 |
| Average Basic Shares Outstanding | 12.74M | 12.72M | 12.72M | 12.71M | 12.68M |
| Average Diluted Shares Outstanding | 12.88M | 12.86M | 12.84M | 12.83M | 12.81M |
| Dividend Per Share | 0.20 | 0.17 | 0.17 | 0.17 | 0.17 |
| Payout Ratio | 132.79% | 38.78% | 37.44% | 46.11% | 36.93% |